How to buy BioSpecifics Technologies (BSTC) shares in the UK

Learn how to easily invest in BioSpecifics Technologies shares.

BioSpecifics Technologies Corp (BSTC) is a publicly traded biotechnology business based in the US. BioSpecifics Technologies is listed on the PINK and employs 7 staff. All prices are listed in US Dollars.

How to buy shares in BioSpecifics Technologies

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: BSTC in this case.
  5. Research BioSpecifics Technologies shares. The platform should provide the latest information available.
  6. Buy your BioSpecifics Technologies shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Share dealing platform comparison

Table: sorted by promoted deals first
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Offer Link
FREE TRADES
IG Share Dealing
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£250
UK: £8
US: £10
EU: 0.1% (min €10)
UK: £3
US: £0
EU: 0.1% (min €10)
£0
Get 0% commission on US shares when you make 3+ trades in the previous month.

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
$10
£0
N/A
£0

Capital at risk

Platform details
OFFER
Fineco
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0
UK: £2.95
US: $3.95
EU: €3.95
N/A
£0
Get £500 in trading commissions to use in the first 3 months (T&Cs apply)

Capital at risk

Platform details
Hargreaves Lansdown Fund and Share Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£1
£11.95
£5.95
£0

Capital at risk

Platform details
Degiro Share Dealing
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0
N/A
£0

Capital at risk

Platform details
loading

Compare up to 4 providers

BioSpecifics Technologies share price (PINK:BSTC)

Use our graph to track the performance of BSTC stocks over time.
Promoted
eToro Free Stocks

Invest in BioSpecifics Technologies shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is BioSpecifics Technologies under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

BioSpecifics Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, BioSpecifics Technologies shares trade at around 38x recent earnings.

PEG ratio

BioSpecifics Technologies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.36. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioSpecifics Technologies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

BioSpecifics Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.6 million (£0.0 million).

The EBITDA is a measure of a BioSpecifics Technologies's overall financial performance and is widely used to measure a its profitability.

BioSpecifics Technologies shares at a glance

Information last updated 2021-01-11.
52-week range$0 - $0
50-day moving average$88.4993
200-day moving average$70.0896
Wall St. target price$88.5
PE ratio37.5127
Dividend yieldN/A (0%)
Earnings per share (TTM)$2.36

BioSpecifics Technologies share dividends

We're not expecting BioSpecifics Technologies to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, BioSpecifics Technologies's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while BioSpecifics Technologies's is 0.2383. This would suggest that BioSpecifics Technologies's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site